250 related articles for article (PubMed ID: 8045961)
1. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
Tiitinen A; Simberg N; Stenman UH; Ylikorkala O
J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961
[TBL] [Abstract][Full Text] [Related]
2. Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism.
Carmina E; Janni A; Lobo RA
J Clin Endocrinol Metab; 1994 Jan; 78(1):126-30. PubMed ID: 8288696
[TBL] [Abstract][Full Text] [Related]
3. High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement.
Simberg N; Tiitinen A; Silfvast A; Viinikka L; Ylikorkala O
J Clin Endocrinol Metab; 1996 Feb; 81(2):646-51. PubMed ID: 8636283
[TBL] [Abstract][Full Text] [Related]
4. Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
Lemay A; Faure N
J Clin Endocrinol Metab; 1994 Dec; 79(6):1716-22. PubMed ID: 7989480
[TBL] [Abstract][Full Text] [Related]
5. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
Andreyko JL; Monroe SE; Jaffe RB
J Clin Endocrinol Metab; 1986 Oct; 63(4):854-9. PubMed ID: 2943756
[TBL] [Abstract][Full Text] [Related]
7. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
[TBL] [Abstract][Full Text] [Related]
8. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
Azziz R; Ochoa TM; Bradley EL; Potter HD; Boots LR
J Clin Endocrinol Metab; 1995 Dec; 80(12):3406-11. PubMed ID: 8530573
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
[TBL] [Abstract][Full Text] [Related]
12. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
[TBL] [Abstract][Full Text] [Related]
14. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
Batukan C; Muderris II
Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
Bayhan G; Bahçeci M; Demirkol T; Ertem M; Yalinkaya A; Erden AC
Clin Exp Obstet Gynecol; 2000; 27(3-4):203-6. PubMed ID: 11214952
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe hirsutism resulting from hyperandrogenism with the reverse sequential cyproterone acetate regimen.
Garner PR; Poznanski N
J Reprod Med; 1984 Apr; 29(4):232-6. PubMed ID: 6232380
[TBL] [Abstract][Full Text] [Related]
18. The grade of hirsutism correlated to serum androgen levels and hormonal indices.
Ruutiainen K; Erkkola R; Kaihola HL; Santti R; Irjala K
Acta Obstet Gynecol Scand; 1985; 64(8):629-33. PubMed ID: 2938400
[TBL] [Abstract][Full Text] [Related]
19. Androgen levels during cyproterone acetate and ethinyl oestradiol treatment of hirsutism.
Rubens R
Clin Endocrinol (Oxf); 1984 Mar; 20(3):313-25. PubMed ID: 6233049
[TBL] [Abstract][Full Text] [Related]
20. Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide.
Rittmaster RS
J Clin Endocrinol Metab; 1988 Oct; 67(4):651-5. PubMed ID: 3138274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
